AVEX

Price has formed sequential lower highs and lower lows under declining EMAs, reinforcing medium- and short-term bearish biases. Recent rallies into the 9- and 20-period EMAs were rejected, confirming supply dominance. Given the Stage 4 downtrend context and tactical resistance at moving averages, execution favors selling now on failed pullbacks.

• ↑Q2 revenue jumped 100% YoY to $201.8 M on new defense contracts.
• ↑FY26 revenue guidance raised to $700–720 M with ~95% of backlog funded.
• ↓Class action lawsuits raise legal and reputational risks.